News
With the aim of being the largest life sector by 2035 behind only the US and China, the UK government is ramping up commercialisation.
Varian has introduced the next-generation microwave ablation solution, IntelliBlate, in Europe to treat soft tissue tumours.
Bio-Techne has announced a collaboration to distribute Spear Bio’s advanced SPEAR UltraDetect immunoassays globally.
Charlie Whelan, a Senior Director of Consulting at GlobalData, discusses the latest trends in medical devices for 2025.
Viome, with Scripps Research, is set to develop and clinically validate the first RNA test for detecting precancerous colon polyps.
The US Food and Drug Administration (FDA) has cleared Caranx Medical’s TAVIPILOT Soft, an artificial intelligence (AI)-based guide software for use during Transcatheter Aortic Valve Implantation (TAVI ...
BD has reached an agreement to merge its Biosciences & Diagnostic Solutions business with Waters Corporation in a nearly $17.5bn deal.
Zimmer Biomet has signed a definitive agreement to acquire orthopaedic robotics company Monogram Technologies.
Researchers at the University of Queensland (UQ) have developed a new device to facilitate drug delivery into the brain safely.
The US FDA has cleared Intuitive's Vessel Sealer Curved for use with the company’s multiport da Vinci surgical systems.
Medical software company Tomoverse Imaging has closed its seed funding round, securing C$5m ($3.65m) for the development of tvCT.
The US Patent and Trademark Office has granted a patent to Geneticure for its genetic test to predict response in renal denervation.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results